Senti Biosciences Inc. (SNTI)
NASDAQ · Healthcare
Senti Biosciences Inc. Operating Income 2021–2025
Senti Biosciences Inc. annual/quarterly operating income history and growth rate from 2021 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Senti Biosciences Inc. operating income for the quarter ending March 31, 2026 was -4.6 M, a 71.85% decrease year-over-year.
- Senti Biosciences Inc. operating income for the twelve months ending March 31, 2026 was -49.6 M, a 45.11% decrease year-over-year.
- Senti Biosciences Inc. annual operating income for 2025 was -68.8 M, a 12.68% increase from 2024.
- Senti Biosciences Inc. annual operating income for 2024 was -61.0 M, a 34.17% decrease from 2023.
- Senti Biosciences Inc. annual operating income for 2023 was -92.7 M, a 49.36% increase from 2022.
- Senti Biosciences Inc. annual operating income for 2022 was -62.1 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Senti Biosciences Inc. Operating Income — FAQ
Senti Biosciences Inc. (SNTI) operating income over the last 5 years — annual and quarterly figures with year-over-year growth and charts.
What is Senti Biosciences Inc.'s operating income?
Senti Biosciences Inc. (SNTI) reported operating income of -$69M for fiscal 2025.
Where can I see SNTI's operating income history?
The chart and table above show Senti Biosciences Inc.'s operating income by year and by quarter, including the growth rate.